Results 201 to 210 of about 1,254,090 (295)

Clinical characteristics and analysis of cerebrospinal fluid biochemical, tumor markers and cytologic indices in 209 patients with meningeal carcinomatosis: a cross-sectional study. [PDF]

Front Oncol
Xu S, Huang C, Ye Y, Lai K, Lan S, Chen J.   +5 more
europepmc   +1 more source

Screening and epitope characterization of Nidogen‐2‐specific nanobodies

FEBS Open Bio, EarlyView.
Camel immunization and phage display were employed to generate high‐affinity VHH nanobodies against Nidogen‐2. After library construction, biopanning, ELISA screening, sequencing, and recombinant expression, selected nanobodies were purified and characterized, leading to the preliminary exploration of a nanobody‐based sandwich ELISA for specific ...
Jianchuan Wen, Qianqian Cui, Zhongyun Lan, Yingjun Wang, Shuaiying Zhao, Wenxuan Feng, Yunfeng Liu, Qiting Huang, Dongna Zhang, Jianfeng Xu   +9 more
wiley   +1 more source

CHANGES OF TSH, IMMUNE, INFLAMMATORY AND TUMOR MARKERS AFTER ANAEROBIC EXERCISE IN ELITE KARATE ATHLETES. [PDF]

Acta Clin Croat
Vidranski T, Vidranski V, Jukić T.
europepmc   +1 more source

Tumor markers in testis tumors.

The Turkish journal of pediatrics, 1984
openaire   +2 more sources

Tumor Markers

Biomedicine & Pharmacotherapy, 2000
openaire   +1 more source

MiR‐513a promotes human erythroid differentiation by modulating c‐Jun

FEBS Open Bio, EarlyView.
During early human erythropoiesis, miR‐513a promoted erythroid differentiation in primary human CD34+ hematopoietic stem‐progenitor cells and human TF‐1 erythroleukemic cells by indirectly decreasing c‐Jun and phospho‐c‐Jun expression, which are associated with increased GATA1 expression.
MinJung Kim, Brittany Taylor, Shannon Bolten, Christian L. Eberly, Mahliya Abdurahman, T. Michael Creed, Acong Yang, Taylor L. Hatchet, Tristan Dyson, Shuo Gu, Curt I. Civin, Tami J. Kingsbury   +11 more
wiley   +1 more source

Editorial: Tumor markers of respiratory tumors: from bench to bedside. [PDF]

Front Med (Lausanne)
Huang W, Yang C, Espinoza JL, Wu L, Wen J.   +4 more
europepmc   +1 more source

Digital twins to accelerate target identification and drug development for immune‐mediated disorders

FEBS Open Bio, EarlyView.
Digital twins integrate patient‐derived molecular and clinical data into personalised computational models that simulate disease mechanisms. They enable rapid identification and validation of therapeutic targets, prediction of drug responses, and prioritisation of candidate interventions.
Anna Niarakis, Philippe Moingeon
wiley   +1 more source

Dual-Functional Fluorescent Probe in the Diagnosis of Liver Injury and the Evaluation of Drug Therapy with Double Signal Amplification

Chemical & Biomedical Imaging
Chenchen Bian, Miaomiao Liu, Jiayi Cheng, Lei Yang, Zhanxian Li, Mingming Yu   +5 more
doaj   +1 more source

The delaying effect of toripalimab on disease progression in patients with advanced hepatocellular carcinoma and changes in serum tumor markers. [PDF]

World J Surg Oncol
Yin Z, Xiao Y, Gu J, Hu P, Jing J, Wang X, Liu Y, Yan S.   +7 more
europepmc   +1 more source